Forte Biosciences Stock Buy Hold or Sell Recommendation
| FBRX Stock | USD 5.80 0.20 3.33% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Forte Biosciences is 'Cautious Hold'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Forte Biosciences given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Forte Biosciences, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Forte Biosciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Forte Stock please use our How to Invest in Forte Biosciences guide. In addition, we conduct extensive research on individual companies such as Forte and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Forte Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Forte |
Execute Forte Biosciences Buy or Sell Advice
The Forte recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Forte Biosciences. Macroaxis does not own or have any residual interests in Forte Biosciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Forte Biosciences' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Above Average | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Forte Biosciences Trading Alerts and Improvement Suggestions
| Forte Biosciences generated a negative expected return over the last 90 days | |
| Forte Biosciences has high historical volatility and very poor performance | |
| Forte Biosciences has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (31.48 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Forte Biosciences currently holds about 38.55 M in cash with (28.71 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.89. | |
| Forte Biosciences has a frail financial position based on the latest SEC disclosures | |
| Over 80.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Forte Biosciences, Inc. Sees Large Drop in Short Interest - Defense World |
Forte Biosciences Returns Distribution Density
The distribution of Forte Biosciences' historical returns is an attempt to chart the uncertainty of Forte Biosciences' future price movements. The chart of the probability distribution of Forte Biosciences daily returns describes the distribution of returns around its average expected value. We use Forte Biosciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Forte Biosciences returns is essential to provide solid investment advice for Forte Biosciences.
| Mean Return | -2.15 | Value At Risk | -12.11 | Potential Upside | 8.94 | Standard Deviation | 6.44 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Forte Biosciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Forte Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as Forte Biosciences, soars without any apparent reason? This usually happens because many institutional investors are aggressively trading Forte Biosciences back and forth among themselves.
| Shares | Longwood Capital Partners Llc | 2024-12-31 | 18.1 K | Geode Capital Management, Llc | 2024-12-31 | 16.9 K | Blackrock Inc | 2024-12-31 | 6.8 K | Royal Bank Of Canada | 2024-12-31 | 3.8 K | Jpmorgan Chase & Co | 2024-12-31 | 2.1 K | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 151 | Group One Trading, Lp | 2024-12-31 | 104 | Tower Research Capital Llc | 2024-12-31 | 100.0 | Comerica Bank | 2024-12-31 | 56.0 | Fred Alger Management, Llc | 2024-12-31 | 1.1 M | Tybourne Capital Management (hk) Ltd | 2024-12-31 | 620 K |
Forte Biosciences Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | 51.8M | (16.7M) | (944K) | (4.0M) | (3.6M) | (3.4M) | |
| Free Cash Flow | (18.4M) | (16.7M) | (8.2M) | (28.8M) | (33.1M) | (34.8M) | |
| Depreciation | 54K | 36K | 0.0 | 9K | 8.1K | 7.7K | |
| Other Non Cash Items | 30.9M | 61K | 3.8M | (131K) | (150.7K) | (143.1K) | |
| Capital Expenditures | 161.6K | 0.0 | 61K | 88K | 79.2K | 75.2K | |
| Net Income | (46.5M) | (21.7M) | (13.9M) | (31.5M) | (36.2M) | (38.0M) | |
| End Period Cash Flow | 58.8M | 42.0M | 41.1M | 37.1M | 42.7M | 33.3M |
Forte Biosciences Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Forte Biosciences or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Forte Biosciences' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Forte stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -2.08 | |
β | Beta against Dow Jones | 0.74 | |
σ | Overall volatility | 6.24 | |
Ir | Information ratio | -0.32 |
Forte Biosciences Volatility Alert
Forte Biosciences is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Forte Biosciences' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Forte Biosciences' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Forte Biosciences Fundamentals Vs Peers
Comparing Forte Biosciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Forte Biosciences' direct or indirect competition across all of the common fundamentals between Forte Biosciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Forte Biosciences or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Forte Biosciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Forte Biosciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Forte Biosciences to competition |
| Fundamentals | Forte Biosciences | Peer Average |
| Return On Equity | -1.37 | -0.31 |
| Return On Asset | -0.68 | -0.14 |
| Current Valuation | 20.72 M | 16.62 B |
| Shares Outstanding | 6.39 M | 571.82 M |
| Shares Owned By Insiders | 9.71 % | 10.09 % |
| Shares Owned By Institutions | 80.06 % | 39.21 % |
| Number Of Shares Shorted | 28.28 K | 4.71 M |
| Price To Book | 3.96 X | 9.51 X |
| EBITDA | (32.48 M) | 3.9 B |
| Net Income | (31.48 M) | 570.98 M |
| Cash And Equivalents | 38.55 M | 2.7 B |
| Cash Per Share | 1.89 X | 5.01 X |
| Total Debt | 3.67 M | 5.32 B |
| Current Ratio | 25.67 X | 2.16 X |
| Book Value Per Share | 6.42 X | 1.93 K |
| Cash Flow From Operations | (28.71 M) | 971.22 M |
| Short Ratio | 0.48 X | 4.00 X |
| Earnings Per Share | (16.38) X | 3.12 X |
| Target Price | 107.0 | |
| Number Of Employees | 11 | 18.84 K |
| Beta | 2.88 | -0.15 |
| Market Capitalization | 37.08 M | 19.03 B |
| Total Asset | 38.98 M | 29.47 B |
| Retained Earnings | (118.52 M) | 9.33 B |
| Working Capital | 34.66 M | 1.48 B |
| Net Asset | 38.98 M |
Note: Acquisition by Chen Hubert C of 7500 shares of Forte Biosciences subject to Rule 16b-3 [view details]
Forte Biosciences Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Forte . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Forte Biosciences Buy or Sell Advice
When is the right time to buy or sell Forte Biosciences? Buying financial instruments such as Forte Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Forte Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Mid Cap ETFs Thematic Idea Now
Mid Cap ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Mid Cap ETFs theme has 70 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Mid Cap ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Forte Stock Analysis
When running Forte Biosciences' price analysis, check to measure Forte Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Forte Biosciences is operating at the current time. Most of Forte Biosciences' value examination focuses on studying past and present price action to predict the probability of Forte Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Forte Biosciences' price. Additionally, you may evaluate how the addition of Forte Biosciences to your portfolios can decrease your overall portfolio volatility.